1
|
Salvatore M, Amato A, Floridia G, Censi F, Ferrari G, Tosto F, Padoan R, Raia V, Cirilli N, Castaldo G, Capoluongo E, Caruso U, Corbetta C, Taruscio D. The Italian External Quality Assessment Program for Cystic Fibrosis Sweat Chloride Test: Does Active Participation Improve the Quality? Int J Environ Res Public Health 2020; 17:ijerph17093196. [PMID: 32375358 PMCID: PMC7246827 DOI: 10.3390/ijerph17093196] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/06/2020] [Revised: 04/26/2020] [Accepted: 04/27/2020] [Indexed: 05/28/2023]
Abstract
(1) Background: Diagnostic testing for cystic fibrosis (CF) is based on a sweat chloride test (SCT) considering the appropriate signs and symptoms of the disease and results of a gene mutation analysis. In 2014, the Istituto Superiore di Sanità (ISS) established a pilot Italian external quality assessment program for CF SCT (Italian EQA-SCT), which is now a third party service carried out by the ISS. (2) Methods: The ongoing scheme is prospective, enrollment is voluntary, and the payment of a fee is required. Results are shared through a dedicated web-facility. Assessment covers the analysis, interpretation, and reporting of results. (3) Results: Thirteen, fifteen, sixteen, and fifteen different laboratories, respectively, participated from 2015 to 2016 and from 2018 to 2019 in the Italian EQA-SCT scheme. Eleven different laboratories participated each year in all four rounds of the Italian EQA-SCT. (4) Conclusions: The overall results obtained from the laboratories participating constantly clearly show that their qualitative and quantitative performance improved significantly. This is due to the opportunity-after receiving the EQA results-to constantly review their performance and address any inconsistencies. We firmly believe that participation in the EQA program will improve the quality of participating laboratories and that EQA participation should become mandatory as a fundamental requirement for laboratory accreditation.
Collapse
Affiliation(s)
- Marco Salvatore
- Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, National Center Rare Diseases, 00161 Rome, Italy; (A.A.); (F.C.); (G.F.); (F.T.); (D.T.)
| | - Annalisa Amato
- Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, National Center Rare Diseases, 00161 Rome, Italy; (A.A.); (F.C.); (G.F.); (F.T.); (D.T.)
| | - Giovanna Floridia
- Unità di Bioetica, Istituto Superiore di Sanità, 00161 Roma, Italia;
| | - Federica Censi
- Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, National Center Rare Diseases, 00161 Rome, Italy; (A.A.); (F.C.); (G.F.); (F.T.); (D.T.)
| | - Gianluca Ferrari
- Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, National Center Rare Diseases, 00161 Rome, Italy; (A.A.); (F.C.); (G.F.); (F.T.); (D.T.)
| | - Fabrizio Tosto
- Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, National Center Rare Diseases, 00161 Rome, Italy; (A.A.); (F.C.); (G.F.); (F.T.); (D.T.)
| | - Rita Padoan
- Centro di Supporto Fibrosi Cistica, Dipartimento Pediatrico, Università di Brescia, ASST Spedali Civili, 25123 Brescia, Italia;
| | - Valeria Raia
- Centro Regionale Fibrosi Cistica, Unità di Pediatria, Dipartimento di Scienze Mediche Traslazionali, Università degli Studi di Napoli, Federico II, 80145 Napoli, Italia;
| | - Natalia Cirilli
- Centro di Riferimento Fibrosi Cistica, Dipartimento Materno Infantile, AOU Ospedali Riuniti, 60121 Ancona, Italia;
| | - Giuseppe Castaldo
- Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II; CEINGE-Biotecnologie avanzate, scarl, 80131 Napoli, Italia; (G.C.); (E.C.)
| | - Ettore Capoluongo
- Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II; CEINGE-Biotecnologie avanzate, scarl, 80131 Napoli, Italia; (G.C.); (E.C.)
| | - Ubaldo Caruso
- LABSIEM—Laboratorio per lo Studio degli Errori Congeniti del Metabolismo, Università degli Studi di Genova—DINOGMI, 16132 Genova, Italia;
| | - Carlo Corbetta
- SC Laboratorio di Riferimento Regionale per lo Screening Neonatale—Regione Lombardia, ASST Fatebenefratelli Sacco, 20157 Milano, Italia;
| | - Domenica Taruscio
- Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, National Center Rare Diseases, 00161 Rome, Italy; (A.A.); (F.C.); (G.F.); (F.T.); (D.T.)
| |
Collapse
|